Evaluating 7-Aminopyrazolo[4,3- d ]pyrimidines as Human A 1 and A 3 Adenosine Receptor Antagonists
Open Access
- 14 May 2026
- journal article
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 11 (20) , 29623-29637
Abstract
This study aimed to improve the adenosine receptor (AR) subtype selectivity of the previously reported 7-benzylamino-1-methyl-3-phenyl-pyrazolo[3,4-d]pyridazine analogue PPZ I, a nanomolar dual nonselective adenosine hA1/hA3 receptor antagonist (Ki = 11 nM hA1R/13 nM hA3R). To this end, 31 novel derivatives bearing the pyrazolo[4,3-d]pyrimidine scaffold were designed and synthesized, incorporating either 7-benzylamino or 7-phenylamino substituents. Binding affinities were determined using a bioluminescence resonance energy transfer assay against hA1R and hA3R, alongside functional characterization of antagonistic activity and selectivity across all four AR subtypes. These studies identified compounds 9 and 40 as the most promising derivatives in the series. Compound 9 exhibited approximately 4-fold selectivity for hA1R over hA3R, whereas compound 40 showed a 10-fold preference for hA3R over hA1R. Both compounds displayed low-affinity binding to the two hA2R subtypes, which was more significant against hA2AR. Overall, compounds 9 and 40 exhibited up to 3- and 6-fold selectivity for hA1R and hA3R, respectively, over the other hAR subtypes. Studies of the binding profile of 9 and 40 inside the orthosteric binding site of hA1R and hA3R showed that the pyrazole ring forming hydrogen bonding interactions with N6.55 was complemented using molecular dynamics simulations and relative binding free energy calculations and validated through site-directed mutagenesis. The findings of this study will lead to the design and synthesis of more effective compounds against hARs that may have a therapeutic effect against human diseases, such as glaucoma and asthma.Keywords
Funding Information
- Royal Society (INF/R2/212001)
- Erasmus+
- Studienstiftung des Deutschen Volkes
- British Pharmacological Society
- University of Cambridge
- China Scholarship Council
- Biotechnology and Biological Sciences Research Council (BB/W014831/1)
- Biotechnology and Biological Sciences Research Council (BB/Y513817/1)
- Hellenic Academic Libraries Link
This publication has 66 references indexed in Scilit:
- Exploring Trisubstituted adenine derivatives as adenosine A1 receptor ligands with antagonist activity: Synthesis, biological evaluation and molecular modellingBioorganic Chemistry, 2025
- Accurate calculation of affinity changes to the close state of influenza A M2 transmembrane domain in response to subtle structural changes of adamantyl amines using free energy perturbation methods in different lipid bilayersBiochimica et Biophysica Acta (BBA) - Biomembranes, 2023
- A live cell NanoBRET binding assay allows the study of ligand-binding kinetics to the adenosine A3 receptorPurinergic Signalling, 2019
- A3 Adenosine receptors mediate oligodendrocyte death and ischemic damage to optic nerveGlia, 2013
- Adenosine Receptors and Asthma2009
- Selective Human Adenosine A3 Antagonists based on Pyrido[2,1‐f]purine‐2,4‐diones: Novel Features of hA3 Antagonist BindingChemMedChem, 2008
- The Amber biomolecular simulation programsJournal of Computational Chemistry, 2005
- Improved protein–ligand docking using GOLDProteins: Structure, Function, and Bioinformatics, 2003
- Development and validation of a genetic algorithm for flexible docking 1 1Edited by F. E. CohenJournal of Molecular Biology, 1997
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973